<DOC>
	<DOCNO>NCT00733967</DOCNO>
	<brief_summary>The primary aim study determine safety tolerability treatment Varenicline methamphetamine-dependent volunteer . The investigator also seek determine effect treatment Varenicline , compare placebo , crave methamphetamine cigarette follow exposure methamphetamine smoking cue , respectively . The effect treatment Varenicline , compare placebo , subjective effect produce administration methamphetamine placebo attempt determine . Lastly , investigator hope determine effect treatment Varenicline , compare placebo , reinforce effect produce administration methamphetamine placebo .</brief_summary>
	<brief_title>Varenicline-Methamphetamine Interaction Study ( 2008 )</brief_title>
	<detailed_description>See Brief Summary</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>English speaking volunteer seek treatment time study Be 1855 year age Meet DSMIV criterion MA dependence Must cigarette smoker , define smoke 10 cigarette per day selfreport Have selfreported history use MA smoke IV route provide least one MApositive urine prior admission Have vital sign follow : resting pulse 50 90 bpm , blood pressure 105150 mm Hg systolic 4590 mm HG diastolic ; criterion must meet within 2 day admission Have hematology chemistry laboratory test within normal ( +/ 10 % ) limit follow exception : ) liver function test ( total Bilirubin , ALT , AST , alkaline phosphatase ) &lt; 3 x upper limit normal , b ) kidney function test ( creatinine BUN ) &lt; 2 x upper limit normal Have baseline EKG demonstrate normal sinus rhythm , normal conduction ( include QTc ) , clinically significant arrhythmia Have medical history brief physical examination demonstrate clinically significant contradiction study participation , judgment admit physician nurse practitioner principal investigator Have history evidence suggestive seizure disorder brain injury Have previous medically adverse reaction MA , include loss consciousness , chest pain , epileptic seizure Have neurological psychiatric disorder , : psychosis , bipolar illness major depression assess MINI ; organic brain disease dementia assess clinical interview ; history psychiatric disorder would require ongoing treatment would make study compliance difficult ; history suicide attempt within past three month assess MINI and/or current suicidal ideation/plan assess MINI Have evidence clinically significant heart disease hypertension , determine PI Have family history firstdegree relatives early cardiovascular morbidity mortality , determine PI Have evidence untreated unstable medical illness include : neuroendocrine , autoimmune , renal , hepatic , active infectious disease Have HIV currently symptomatic , diagnosis AIDS , receive antiretroviral medication Be pregnant nursing . Other female must either unable conceive ( i.e. , surgically sterilize , sterile , postmenopausal ) use reliable form contraception ( e.g. , abstinence , birth control pill , intrauterine device , condom , spermicide ) . All female must provide negative pregnancy urine test study entry , upon hospital admission , end study participation Have asthma currently use alpha beta agonist , theophylline , sympathomimetics Have illness , condition , use psychotropic medication , opinion PI and/or admit physician nurse practitioner would preclude safe and/or successful completion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Methamphetamine</keyword>
	<keyword>Chantix</keyword>
	<keyword>Varenicline</keyword>
</DOC>